China (Mainland)
Premiumsupplier
Top Quality Pharmaceutical Intermediates Gliclazide CAS 21187-98-4 CAS NO.21187-98-4
- Min.Order: 1 Kilogram
- Payment Terms: L/C,T/T,Other
- Product Details
Keywords
- Gliclazide
- 21187-98-4
- C15H21N3O3S
Quick Details
- ProName: Top Quality Pharmaceutical Intermediat...
- CasNo: 21187-98-4
- Molecular Formula: C15H21N3O3S
- Appearance: white Powder
- Application: Organic intermediate
- DeliveryTime: as customers request
- PackAge: 1-5KG/Tin or Bag,25KG/Drum, 200KG/Drum
- Port: any port in China
- ProductionCapacity: 1000 Metric Ton/Year
- Purity: >99%
- Storage: Cool Dry Place
- Transportation: by sea or by air
- LimitNum: 1 Kilogram
Superiority
| 1)Quick Response Within 12 hours; |
| 2)Quality Guarantee: All products are strictly tested by our QC, confirmed by QA and approved by third party lab in China, USA, Canada, Germany, UK, Italy, France etc. |
| 3) OEM/ODM Available; |
| 4) Reasonable & Competitive Price; |
| 5) Fast Delivery: Samples from stock; bulk products within 7 days; |
| 6) Professional Documents for Your Clearance; |
| 7) Economic Freight Save Your Cost; |
| 8) All your money be refund immediately if quality issue happens. |
Details
Product Description
| CAS.No | 21187-98-4 |
| Product name | Gliclazide |
| MF | C15H21N3O3S |
| MW | 323.41 |
| EINECS | 244-260-5 |
Function
Gliclazide is an oral antihyperglycemic agent used for the treatment of diabetes mellitus type II
1. Hypoglycemic effect: gliclazide is the second-generation oral sulfonylurea hypoglycemic agents. Its role is more than ten times stronger than tolbutamide.
2. It can reduce platelet aggregation and adhesion, and prevent fibrin depositing in the microvasculature.
3. It can lower cholesterol savings, and reduce plasma concentrations of arterial triphosphate glycerides and fatty acids. The role of the three not only can treat diabetes metabolic disorders, but also prevent and treat complications like the development and progression of diabetes-blood vessels, retinal, renal disease.